Corcept Therapeutics (CORT) EBIT (2010 - 2026)
Corcept Therapeutics (CORT) recorded EBIT of $41.3 million in Q2 2026, up 54.8% from $26.68 million a year earlier.
Powered by 
Analysis
Corcept Therapeutics (CORT) EBIT (2010 - 2026) Analysis & Trends
On a TTM basis, Corcept Therapeutics' EBIT came in at $6.41 million as of Jun 30, 2026, down 93.7% year-over-year; for FY2025, it was $44.8 million, down 67.3% from FY2024.
- Annual EBIT has a five-year compound annual growth rate of -19.0% (FY2020 to FY2025).
- Across earlier years, EBIT came in at $136.95 million in FY2024 (+27.7%), $107.28 million in FY2023 (-4.8%), $112.63 million in FY2022 (-9.5%) and $124.48 million in FY2021 (-2.9%).
- The Q2 2026 figure is the highest quarterly EBIT since Q3 2024.
- On a year-over-year basis, EBIT rose in two of the last seven quarters, with an average decline of 27.1%.
- Peak year-over-year performance for EBIT in the last five years was growth of 98.6% in Q1 2024, against a decline of 88.4% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -$49.6 million (Q1 2026), $4.49 million (Q4 2025) and $10.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Corcept Therapeutics | 12.50 Bn | 11.06 Bn | 252.09 Mn | 41.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.30 Mn |
| Mar 31, 2026 | -49.60 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Sep 30, 2025 | 10.22 Mn |
| Jun 30, 2025 | 26.68 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 25.26 Mn |
| Sep 30, 2024 | 46.60 Mn |
| Jun 30, 2024 | 35.59 Mn |
| Mar 31, 2024 | 29.50 Mn |
| Dec 31, 2023 | 31.67 Mn |
| Sep 30, 2023 | 31.18 Mn |
| Jun 30, 2023 | 29.58 Mn |
| Mar 31, 2023 | 14.85 Mn |
| Dec 31, 2022 | 22.50 Mn |
| Sep 30, 2022 | 31.93 Mn |
| Jun 30, 2022 | 31.43 Mn |
| Mar 31, 2022 | 26.77 Mn |
| Dec 31, 2021 | 36.66 Mn |
| Sep 30, 2021 | 36.23 Mn |
API Access
Corcept Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();